Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04416321 · ClinicalTrials.gov registry record · NA
A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced.
A NA study, sponsored by Invibio.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04416321 is a NA study that has completed, run by Invibio. The registered enrollment target is 25 participants.
The verdict
NCT04416321, a NA study, has completed, sponsored by Invibio.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this trial is to collect clinical outcomes including radiographic and CT outcomes in patients who undergo spinal fusion using the Keos Lumbar Interbody Fusion Device.
Interventions
- DEVICE Surgery with the Keos Lumbar Interbody Fusion Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2026-01-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04416321
The ClinicalTrials.gov registry entry for NCT04416321 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Invibio, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Surgery with the Keos Lumbar Interbody Fusion Device is the first listed.
NCT04416321 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04416321 about?
NCT04416321 is a clinical study titled "A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced.". The purpose of this trial is to collect clinical outcomes including radiographic and CT outcomes in patients who undergo spinal fusion using the Keos Lumbar Interbody Fusion Device.
What is the current status of trial NCT04416321?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2021-07-01. Estimated completion is 2026-01-27.
What interventions are being tested in trial NCT04416321?
The interventions under investigation include: Surgery with the Keos Lumbar Interbody Fusion Device (DEVICE).
Who is sponsoring clinical trial NCT04416321?
This trial is sponsored by Invibio, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.